Key facts
- Locate Bio’s last known valuation is $43.5M.
- It has raised $37.2M; the latest was Later Stage VC ($11.5M) in May 2024.
- Notable investors include Innovate UK, Mercia Ventures, BGF (Financial Services), Wellcome Trust, Midlands Engine Investment Fund — 7 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 7 names
- ·Watchlist + deal alerts for Locate Bio
- ·The full record, as it builds
Funding rounds
No funding rounds for Locate Bio are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Locate Bio
Developer of a regenerative medicine platform designed to help surgeons restore patients' lives through research, innovation, and performance. The company's platform develops thermally activated and injectable scaffolds that solidify within the body and can be used to support tissue growth before degrading away, enabling pharmaceutical delivery, medical devices, and biotechnology companies to provide advanced delivery systems and regenerative matrices.
- Sector
- Healthcare
- HQ
- Nottingham, United Kingdom
- Founded
- 2001
- Employees
- 25
- Website
- locatebio.com/
- Ownership
- Privately Held (backing)
Locate Bio doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Locate Bio shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Locate Bio in its N-PORT filings yet. We sweep new filings monthly.